NCT02302807 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 464
- group Id
- BG001
- value
- 467
- group Id
- BG002
- value
- 931
- units
- Participants
- groups
- description
- Participants randomized to the chemotherapy arm received vinflunine, paclitaxel, or docetaxel per the investigators choice. Vinflunine 320 milligrams per square meter (mg/m\^2), paclitaxel 175 mg/m\^2, or docetaxel 75 mg/m\^2 were administered intravenously on Day 1 of each 21-day cycle until disease progression per standard RECIST v1.1 or unacceptable toxicity.
- id
- BG000
- title
- Chemotherapy (Vinflunine, Paclitaxel, or Docetaxel)
- description
- Atezolizumab was administered intravenously at a fixed dose of 1200 milligrams (mg) on Day 1 of each 21-day cycle. Participants received atezolizumab as long as they continued to experience clinical benefit in the opinion of the investigator until unacceptable toxicity or symptomatic deterioration attributed to disease progression as determined by the investigator.
- id
- BG001
- title
- Atezolizumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.3
- value
- 66.1
- group Id
- BG001
- spread
- 9.6
- value
- 65.9
- group Id
- BG002
- spread
- 9.4
- value
- 66.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 103
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 213
- title
- Female
- measurements
- group Id
- BG000
- value
- 361
- group Id
- BG001
- value
- 357
- group Id
- BG002
- value
- 718
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 29
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 368
- group Id
- BG001
- value
- 363
- group Id
- BG002
- value
- 731
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 80
- group Id
- BG001
- value
- 91
- group Id
- BG002
- value
- 171
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 118
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 336
- group Id
- BG001
- value
- 335
- group Id
- BG002
- value
- 671
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 70
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 138
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 464
- group Id
- BG001
- value
- 467
- group Id
- BG002
- value
- 931
- units
- Participants
- groups
- description
- Participants randomized to the chemotherapy arm received vinflunine, paclitaxel, or docetaxel per the investigators choice. Vinflunine 320 milligrams per square meter (mg/m\^2), paclitaxel 175 mg/m\^2, or docetaxel 75 mg/m\^2 were administered intravenously on Day 1 of each 21-day cycle until disease progression per standard RECIST v1.1 or unacceptable toxicity.
- id
- BG000
- title
- Chemotherapy (Vinflunine, Paclitaxel, or Docetaxel)
- description
- Atezolizumab was administered intravenously at a fixed dose of 1200 milligrams (mg) on Day 1 of each 21-day cycle. Participants received atezolizumab as long as they continued to experience clinical benefit in the opinion of the investigator until unacceptable toxicity or symptomatic deterioration attributed to disease progression as determined by the investigator.
- id
- BG001
- title
- Atezolizumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.3
- value
- 66.1
- group Id
- BG001
- spread
- 9.6
- value
- 65.9
- group Id
- BG002
- spread
- 9.4
- value
- 66.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 103
- group Id
- BG001
- value
- 110
- group Id
- BG002
- value
- 213
- title
- Female
- measurements
- group Id
- BG000
- value
- 361
- group Id
- BG001
- value
- 357
- group Id
- BG002
- value
- 718
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 29
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 368
- group Id
- BG001
- value
- 363
- group Id
- BG002
- value
- 731
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 80
- group Id
- BG001
- value
- 91
- group Id
- BG002
- value
- 171
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 118
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 336
- group Id
- BG001
- value
- 335
- group Id
- BG002
- value
- 671
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 70
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 138
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle